AMICUS THERAPEUTICS, INC. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-12-31

Reporting Person: Rosenberg Ellen (Chief Legal Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-31	Common Stock	F	4751	$23.09	Disposed	190418	Direct
2021-01-02	Common Stock	F	6475	$23.09	Disposed	183943	Direct
2021-01-03	Common Stock	F	8306	$23.09	Disposed	175637	Direct
2021-01-04	Common Stock	A	33131	—	Acquired	208768	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-04	Stock Options (right to buy)	$21.78	A	53355	Acquired	2031-01-04	Common Stock (53355)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15000	Indirect

Footnotes

F1: Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.

F2: The Restricted Stock Units will vest in four equal annual installments beginning on January 4, 2022.

F3: These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.